S&P 500
(0.23%) 5 111.59 points
Dow Jones
(0.34%) 38 369 points
Nasdaq
(0.27%) 15 971 points
Oil
(-1.29%) $82.77
Gas
(6.34%) $2.05
Gold
(-0.09%) $2 345.20
Silver
(-0.27%) $27.46
Platinum
(3.95%) $958.55
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.33%) $10.99
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.65%) $93.39

实时更新: SSY Group Ltd [2005.HK]

交易所: HKSE 工业: Pharmaceuticals, Biotechnology & Life Sciences
最后更新时间29 Apr 2024 @ 16:08

-0.42% HKD 4.77

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 16:08):

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally...

Stats
今日成交量 2.42M
平均成交量 2.05M
市值 14.16B
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.0700 ( 2023-09-14 )
Next Dividend HKD0 ( N/A )
P/E 10.84
ATR14 HKD0.00700 (0.15%)

音量 相关性

長: -0.12 (neutral)
短: -0.43 (neutral)
Signal:(48.323) Neutral

SSY Group Ltd 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

SSY Group Ltd 相关性 - 货币/商品

The country flag 0.11
( neutral )
The country flag -0.19
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.67
( moderate )
The country flag -0.22
( neutral )

SSY Group Ltd 财务报表

Annual 2023
营收: HKD6.46B
毛利润: HKD3.49B (53.99 %)
EPS: HKD0.440
FY 2023
营收: HKD6.46B
毛利润: HKD3.49B (53.99 %)
EPS: HKD0.440
FY 2022
营收: HKD6.43B
毛利润: HKD3.44B (53.46 %)
EPS: HKD0.380
FY 2021
营收: HKD5.36B
毛利润: HKD3.17B (59.18 %)
EPS: HKD0.260

Financial Reports:

No articles found.

SSY Group Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0600
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.160
(N/A)
HKD0.0700
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

SSY Group Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.77 - Increase likely (55.42%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.00500 2008-05-23
Last Dividend HKD0.0700 2023-09-14
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 32 --
Total Paid Out HKD1.257 --
Avg. Dividend % Per Year 0.00% --
Score 4.32 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.77
Div. Directional Score 10.00 --
Next Divdend (Est)
(2024-07-09)
HKD0.0719 Estimate 12.38 %
Dividend Stability
0.50 Below Average
Dividend Score
4.32
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9909.HK Ex Dividend Knight 2023-11-24 Semi-Annually 0 0.00%
2161.HK Ex Dividend Junior 2023-08-15 Annually 0 0.00%
1161.HK Ex Dividend Knight 2023-06-12 Annually 0 0.00%
0239.HK Ex Dividend Knight 2023-09-29 Semi-Annually 0 0.00%
3866.HK Ex Dividend Junior 2023-06-02 Annually 0 0.00%
1731.HK Ex Dividend Junior 2023-06-23 Sporadic 0 0.00%
0771.HK Ex Dividend Junior 2023-05-31 Sporadic 0 0.00%
2327.HK Ex Dividend Junior 2023-08-03 Sporadic 0 0.00%
1290.HK Ex Dividend Junior 2023-06-14 Sporadic 0 0.00%
0363.HK Ex Dividend Knight 2023-06-01 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2041.5005.928.88[0 - 0.5]
returnOnAssetsTTM0.1101.2006.337.59[0 - 0.3]
returnOnEquityTTM0.1991.5008.9110.00[0.1 - 1]
payoutRatioTTM0.338-1.0006.62-6.62[0 - 1]
currentRatioTTM2.030.8004.843.87[1 - 3]
quickRatioTTM1.5870.8005.374.30[0.8 - 2.5]
cashRatioTTM0.6591.5007.4510.00[0.2 - 2]
debtRatioTTM0.282-1.5005.31-7.96[0 - 0.6]
interestCoverageTTM11.881.0006.716.71[3 - 30]
operatingCashFlowPerShareTTM0.3252.009.8910.00[0 - 30]
freeCashFlowPerShareTTM0.08802.009.9610.00[0 - 20]
debtEquityRatioTTM0.486-1.5008.06-10.00[0 - 2.5]
grossProfitMarginTTM0.5401.0004.344.34[0.2 - 0.8]
operatingProfitMarginTTM0.2311.0007.397.39[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2871.0009.529.52[0.2 - 2]
assetTurnoverTTM0.5400.8009.737.79[0.5 - 2]
Total Score12.25

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.781.0009.010[1 - 100]
returnOnEquityTTM0.1992.509.3010.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.08802.009.9710.00[0 - 30]
dividendYielPercentageTTM4.811.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.3252.009.8910.00[0 - 30]
payoutRatioTTM0.3381.5006.62-6.62[0 - 1]
pegRatioTTM0.5591.5009.610[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1491.0008.760[0.1 - 0.5]
Total Score7.77

SSY Group Ltd

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。